Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2011

View Archived Issues

Phase II study assesses BAF-312 in relapsing-remitting MS

Imaging agent [123I]-BZM-055 assessed in nonhuman primates

Lostam BioPharmaceutical presents monoclonal antibodies against P. aeruginosa flagellin

Scientists in Sweden identify new biomarker for disease activity in MS

Natural plant-derived product inhibits proliferation of gastric cancer cells

Novel sterol O-acyltransferase 2 inhibitors synthesized in Japan

New HIV integrase inhibitors presented by Critical Outcome Technologies

Johnson & Johnson submits sNDA to FDA for Nucynta ER

Circadian Technologies clear to start clinical development of VGX-100

Actelion Pharmaceuticals discloses novel antibacterials

Sanofi presents new Met inhibitors

Galena Biopharma focuses on late-stage targeted cancer drug development

Piramal Life Sciences synthesizes new cytokine inhibitors

Takeda Pharmaceutical prepares novel histamine H3 receptor antagonists

TNF-Kinoid shows promise in phase IIa trial

CytRx reports further on phase Ib/II study of INNO-206

FDA approves Pacira Pharmaceuticals' Exparel

European orphan drug status for Celldex Therapeutics' rindopepimut

Takara Bio to develop gene therapy for non-Hodgkin's lymphoma

MorphoSys and Shionogi extend HuCAL research partnership

Phase II study of CK-2017357 advances

NVB-302 enters clinical testing

Infinity Pharmaceuticals begins two studies of IPI-145

FDA approves Xience Prime stent

Avanir Pharmaceuticals submits MAA for Nuedexta

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...